Efficacy and Safety Study of Jaktinib in Subjects With Active Ankylosing Spondylitis(AS)

NCT05861102 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

265

Enrollment

INDUSTRY

Sponsor class

Conditions

Ankylosing Spondylitis

Interventions

DRUG: Jaktinib
DRUG: Placebo

Sponsor

Suzhou Zelgen Biopharmaceuticals Co.,Ltd